146 related articles for article (PubMed ID: 15012687)
1. Anticoagulation during haemodialysis in patients at high-risk of bleeding.
Kim YG
Nephrology (Carlton); 2003 Oct; 8 Suppl():S23-7. PubMed ID: 15012687
[TBL] [Abstract][Full Text] [Related]
2. Hemodialysis using heparin-bound Hemophan in patients at risk of bleeding.
Lee KB; Kim B; Lee YH; Yoon SJ; Kang WH; Huh W; Kim DJ; Oh HY; Kim YG
Nephron Clin Pract; 2004; 97(1):c5-10. PubMed ID: 15153761
[TBL] [Abstract][Full Text] [Related]
3. [Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
Ryckelynck JP; Chouraqui D; Lobbedez T
Nephrologie; 1998; 19(4):223-5. PubMed ID: 9675763
[TBL] [Abstract][Full Text] [Related]
4. [Anticoagulation and chronic hemodialysis].
Zerbi S; Pedrini LA
G Ital Nefrol; 2007; 24(5):381-95. PubMed ID: 17886208
[TBL] [Abstract][Full Text] [Related]
5. Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study.
François K; Wissing KM; Jacobs R; Boone D; Jacobs K; Tielemans C
BMC Nephrol; 2014 Jul; 15():104. PubMed ID: 24993584
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
Nowak G; Bucha E; Brauns I; Czerwinski R
Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
[TBL] [Abstract][Full Text] [Related]
7. [Acute renal failure - anticoagulation in continuous renal replacement therapy].
Hein OV; Birnbaum J; Spies C
Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Apr; 43(4):294-301; quiz 302. PubMed ID: 18409124
[TBL] [Abstract][Full Text] [Related]
8. [Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy].
Steinfeldt T; Rolfes C
Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Apr; 43(4):304-10; quiz 312. PubMed ID: 18409125
[TBL] [Abstract][Full Text] [Related]
9. Minimizing hemorrhagic complications in dialysis patients.
Lohr JW; Schwab SJ
J Am Soc Nephrol; 1991 Nov; 2(5):961-75. PubMed ID: 1760540
[TBL] [Abstract][Full Text] [Related]
10. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
Evenepoel P; Dejagere T; Verhamme P; Claes K; Kuypers D; Bammens B; Vanrenterghem Y
Am J Kidney Dis; 2007 May; 49(5):642-9. PubMed ID: 17472846
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of four modes of low-dose anticoagulation during intermittent haemodialysis.
Skagerlind MSE; Stegmayr BG
Eur J Clin Pharmacol; 2018 Mar; 74(3):267-274. PubMed ID: 29198062
[TBL] [Abstract][Full Text] [Related]
12. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding.
Pinnick RV; Wiegmann TB; Diederich DA
N Engl J Med; 1983 Feb; 308(5):258-61. PubMed ID: 6848936
[No Abstract] [Full Text] [Related]
13. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy.
Nagarik AP; Soni SS; Adikey GK; Raman A
Saudi J Kidney Dis Transpl; 2010 May; 21(3):478-83. PubMed ID: 20427872
[TBL] [Abstract][Full Text] [Related]
14. Avoiding Systemic Heparinization During Hemodialysis: How the Dialysis Setup Might Help.
Janssens FV; Meijers B; François K
Semin Nephrol; 2023 Nov; 43(6):151483. PubMed ID: 38220473
[TBL] [Abstract][Full Text] [Related]
15. Essentials of anticoagulation in hemodialysis.
Fischer KG
Hemodial Int; 2007 Apr; 11(2):178-89. PubMed ID: 17403168
[TBL] [Abstract][Full Text] [Related]
16. Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate.
Evenepoel P; Maes B; Vanwalleghem J; Kuypers D; Messiaen T; Vanrenterghem Y
Am J Kidney Dis; 2002 Feb; 39(2):315-23. PubMed ID: 11840372
[TBL] [Abstract][Full Text] [Related]
17. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.
Meijers B; Metalidis C; Vanhove T; Poesen R; Kuypers D; Evenepoel P
Nephrol Dial Transplant; 2017 Apr; 32(4):707-714. PubMed ID: 28407129
[TBL] [Abstract][Full Text] [Related]
18. Review: anticoagulation for haemodialysis.
Suranyi M; Chow JS
Nephrology (Carlton); 2010 Jun; 15(4):386-92. PubMed ID: 20609088
[TBL] [Abstract][Full Text] [Related]
19. The safety of heparins in end-stage renal disease.
Sonawane S; Kasbekar N; Berns JS
Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
[TBL] [Abstract][Full Text] [Related]
20. Rationale and design of the HepZero study: a prospective, multicenter, international, open, randomized, controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane (Evodial) versus standard care: study protocol for a randomized controlled trial.
Rossignol P; Dorval M; Fay R; Ros JF; Loughraieb N; Moureau F; Laville M
Trials; 2013 Jun; 14():163. PubMed ID: 23725299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]